Literature DB >> 7843199

Phenylketonuria and some aspects of emotional development.

M M Hendrikx1, L W van der Schot, F M Slijper, J Huisman, A F Kalverboer.   

Abstract

Early dietary treatment of phenylketonuria (PKU) prevents intellectual retardation and gross neurological impairment although not all neuropsychological problems. This study investigates to what extent the illness and its treatment imposes a burden on emotional development of early-treated PKU patients and on rearing practices of their parents. It is concluded that in early-treated PKU it is particularly difficult to find constructive ways to adapt to the situation for children as well as for parents. As coping with PKU and its treatment is so complicated, paediatric control should be combined with psychocounselling.

Entities:  

Mesh：

Year:  1994        PMID： 7843199     DOI： 10.1007/bf01972893

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  14 in total

1.  Preliminary neuropsychological test results.

Authors:  L M de Sonneville; E Schmidt; U Michel; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

2.  Mental health in Dutch children: (I). A cross-cultural comparison.

Authors:  F C Verhulst; G W Akkerhuis; M Althaus
Journal:  Acta Psychiatr Scand Suppl       Date:  1985

3.  Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register.

Authors:  I Smith; M G Beasley; O H Wolff; A E Ades
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

4.  Perceptual-motor functioning in children with phenylketonuria.

Authors:  E Koff; P Boyle; S M Pueschel
Journal:  Am J Dis Child       Date:  1977-10

5.  Neuropsychology of early-treated phenylketonuria: specific executive function deficits.

Authors:  M C Welsh; B F Pennington; S Ozonoff; B Rouse; E R McCabe
Journal:  Child Dev       Date:  1990-12

6.  Children with phenylketonuria: the interface of family and child functioning.

Authors:  S Shulman; R O Fisch; C E Zempel; O Gadish; P N Chang
Journal:  J Dev Behav Pediatr       Date:  1991-10       Impact factor: 2.225

7.  Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.

Authors:  G M Realmuto; B D Garfinkel; M Tuchman; M Y Tsai; P N Chang; R O Fisch; S Shapiro
Journal:  J Nerv Ment Dis       Date:  1986-09       Impact factor: 2.254

8.  Behavioural deviance in children with early treated phenylketonuria.

Authors:  J E Stevenson; J Hawcroft; M Lobascher; I Smith; O H Wolff; P J Graham
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

9.  [Intellectual development of patients with phenylketonuria; 15-year national screening in The Netherlands].

Authors:  J Huisman; L W van der Schot; M M Hendrikx; A F Kalverboer; F M Slijper
Journal:  Ned Tijdschr Geneeskd       Date:  1992-11-14

10.  Phenylketonuria with normal intelligence.

Authors:  D A Primrose
Journal:  J Ment Defic Res       Date:  1983-12
View more
  10 in total

Review 1.  Phenylketonuria: old disease, new approach to treatment.

Authors:  H L Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Outcomes of phenylketonuria with relevance to follow-up.

Authors:  F J van Spronsen; A Bélanger-Quintana
Journal:  JIMD Rep       Date:  2011-06-22

3.  Wechsler subscale IQ and subtest profile in early treated phenylketonuria.

Authors:  P V Griffiths; C Demellweek; N Fay; P H Robinson; D C Davidson
Journal:  Arch Dis Child       Date:  2000-03       Impact factor: 3.791

4.  Behaviour and school achievement in patients with early and continuously treated phenylketonuria.

Authors:  B A Stemerdink; A F Kalverboer; J J van der Meere; M W van der Molen; J Huisman; L W de Jong; F M Slijper; P H Verkerk; F J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

5.  The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.

Authors:  A M Bosch; W Tybout; F J van Spronsen; H W de Valk; F A Wijburg; M A Grootenhuis
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

6.  Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.

Authors:  Ana Maria Martins; Andre Luiz Santos Pessoa; Andrea Amaro Quesada; Erlane Marques Ribeiro
Journal:  Mol Genet Metab Rep       Date:  2020-07-22

7.  Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.

Authors:  F Rey; V Abadie; F Plainguet; J Rey
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

Review 8.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

9.  High levels of orexin A in the brain of the mouse model for phenylketonuria: possible role of orexin A in hyperactivity seen in children with PKU.

Authors:  Sankar Surendran; Gerald A Campbell; Stephen K Tyring; Kimberlee Matalon; J David McDonald; Reuben Matalon
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

Review 10.  Mild hyperphenylalaninemia: to treat or not to treat.

Authors:  Francjan J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.